<DOC>
	<DOCNO>NCT00367939</DOCNO>
	<brief_summary>The purpose study evaluate efficacy valsartan plus amlodipine hypertensive patient respond treatment ACE inhibitor plus calcium channel blocker</brief_summary>
	<brief_title>Efficacy Safety Combination Valsartan Plus Amlodipine Hypertensive Patients Not Adequately Responding Combination Therapy With Ramipril Plus Felodipine</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male female patient ( 18 year old ) Females must either postmenopausal one year , surgically sterile use effective contraceptive method ( e.g . barrier method spermicide , intrauterine device , hormonal contraceptive ) . Patients moderate essential hypertension ( WHO II ) Severe hypertension Pregnant nursing woman Treated hypertensive patient control hypertension current therapy ( MSDBP &lt; 90 mmHg MSSBP &lt; 140 mmHg ) A history cardiovascular disease , include angina pectoris , myocardial infarction , coronary artery bypass graft , percutaneous transluminal coronary angioplasty , transient ischemic attack , stroke , heart failure NYHA II IV Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Hypertension</keyword>
</DOC>